Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients

BACKGROUND: Patient selection for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is critically important to optimizing outcomes. There is currently no literature regarding the safety of CRS/HIPEC in patients with cirrhosis. The aim of this case series is to report...

Descripción completa

Detalles Bibliográficos
Autores principales: Weiss, Anna, Ward, Erin P., Baumgartner, Joel M., Lowy, Andrew M., Kelly, Kaitlyn J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922306/
https://www.ncbi.nlm.nih.gov/pubmed/29699564
http://dx.doi.org/10.1186/s12957-018-1389-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922306/
https://www.ncbi.nlm.nih.gov/pubmed/29699564
http://dx.doi.org/10.1186/s12957-018-1389-3

Ejemplares similares